Virologic rebounds following mpox vaccination appear to be uncommon in people living with HIV (PLWH), according to a new study presented by investigators with the Fondazione Policlinico A. Gemelli IRCCS and the Università Cattolica del Sacro…
Category: 6. Health
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Data Show Growing Trend in Insurance/Racial OS Disparities in Breast Cancer
Survival disparities by health insurance and race among patients with newly diagnosed breast cancer have widened in the US, according to findings from an American Cancer Study (ACS)–led study presented at the 2025 American Society of Clinical…
Continue Reading
-
25 Years of Clostridioides difficile Deaths Reveal Who Is Most at Risk—and Where IPC Can Bend the Curve
Atlanta, Georgia, USA
(Adobe Stock by SeanPavonePhoto)
A quarter-century analysis presented at IDWeek 2025, held in Atlanta, Georgia, from October 19 to 22, 2025, puts fresh numbers and urgency behind the work infection preventionists (IPs) do…
Continue Reading
-
Drug Combo Therapy Lowers Death Risk by Over 40%
Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images - A drug combination already used in advanced prostate cancer now appears to significantly…
Continue Reading
-
COVID-19 Vaccines: Navigating the Chaos of Conflicting Guidance – Medscape
- COVID-19 Vaccines: Navigating the Chaos of Conflicting Guidance Medscape
- New US COVID guidance makes getting a shot harder Reuters
- Confused about current vaccine recommendations? Here’s what to know Pittsburgh Post-Gazette
- Prescriptions no…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
HIV preventive treatment could be sold for one thousandth of current list price
At a Glance
- Lenacapavir, a twice-yearly injection to prevent or treat HIV infection, could be mass produced for as low as $25 per patient per year, according to a new study.
- A generic version of lenacapavir could cost $35-$46 per patient per year…
Continue Reading
-
Experts say RSV antibody shot is safe for babies with vaccinated moms
Babies can be safely administered antibody protection against respiratory syncytial virus after birth even if their moms had RSV vaccination while pregnant, a new study says.
An antibody shot called nirsevimab (Beyfortus) is available after…
Continue Reading